|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 12 of 14 found articles
| Title: |
Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial |
| Author: |
Edupuganti, Srilatha Hurt, Christopher B Stephenson, Kathryn E Huang, Yunda Paez, Carmen A Yu, Chenchen Yen, Catherine Hanscom, Brett He, Zonglin Miner, Maurine D Gamble, Theresa Heptinstall, Jack Seaton, Kelly E Domin, Elizabeth Lin, Bob C McKee, Krisha Doria-Rose, Nicole Regenold, Stephanie Spiegel, Hans Anderson, Maija McClosky, Nadia Zhang, Lily Piwowar-Manning, Estelle Ackerman, Margaret E Pensiero, Michael Dye, Bonnie J Landovitz, Raphael J Mayer, Kenneth Siegel, Marc Sobieszczyk, Magdalena Walsh, Stephen R Gama, Lucio Barouch, Dan H Montefiori, David C Tomaras, Georgia D |
| Appeared in: |
The Lancet. HIV |
| Paging: | Volume 12 () nr. 1 pages e13-e25 |
| Year: |
2025 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 12 of 14 found articles
| << previous | next >> |